Stock Pick Coverage

Azure cloud and Copilot AI integration create multi-year revenue tailwinds. Microsoft's wide moat across enterprise software, gaming, and developer tools compounds earnings power. Targeting 18–20% EPS CAGR through 2026.

Data center GPU demand from AI training and inference remains at infrastructure-level urgency. CUDA moat is near-irreplaceable. Gross margins expanding as custom silicon competition lags 2–3 years behind.

AWS re-acceleration and advertising margin expansion drive a multi-year free cash flow inflection. Retail profitability restructuring is ahead of plan. Among the best risk/reward in mega-cap tech.

Ad pricing power returning as Reels monetization matures. AI-driven content recommendations boosting engagement metrics. Disciplined opex approach after 2023 restructuring unlocks significant margin upside.

Enterprise workflow platform with near-100% renewal rates and expanding GenAI module upsell. Net New ACV guidance ahead of estimates. Premium valuation justified by the quality of the recurring revenue base.

Best-in-class XDR/SIEM platform with a sticky agent installed base. Post-incident (2024 outage) customer retention held firm. We await a cleaner entry point near $260 before upgrading to Buy.

Fortress balance sheet with $160B+ cash, trading near 1.4× book value. Warren Buffett's track record and opportunistic capital deployment make this a core defensive compounder for any long-term portfolio.

Trading at 8× forward earnings — deeply discounted despite generating $10B+ in annual free cash flow. Health services segment (Aetna + Oak Street) is undercredited. Dividend yield of 3.9% provides downside cushion.

Deep value turnaround with foundry pivot under Pat Gelsinger. Trading at Price/Book lows not seen since the 1990s. Execution risk remains high — we want to see Gaudi 3 AI chip traction before recommending.

IQOS smoke-free device is converting smokers at an accelerating pace in Europe and Asia. Tobacco pricing power + growth product mix = a compelling income + transition story at 16× earnings.

Best-managed large bank globally. NIM expansion from higher-for-longer rates, fee income diversification, and conservative loan loss reserves give JPM resilience others lack. Trading at 12× earnings.

🌱 Clean Energy: Best-in-class micro-inverter with recurring software revenue from the IQ Gateway platform. Monitoring inventory destocking and rate sensitivity before upgrading.

🏥 Healthcare AI: da Vinci surgical robot installed base growing globally. Ion bronchoscopy system opening a new market. Razor/blade model generates 70%+ gross margins on instruments and accessories.

⚡ Power Infrastructure: Data center electricity demand is surging and regulated utilities can't keep up. Vistra's merchant generation fleet — including nuclear — is uniquely positioned to supply AI hyperscalers.

💊 GLP-1 Obesity: Mounjaro and Zepbound are redefining treatment for obesity and type 2 diabetes. Manufacturing scale is the key bottleneck — Lilly's capital investment program is ahead of peers. Multi-decade growth runway.

🤖 Government AI: AIP bootcamp flywheel driving commercial acceleration. US government contract base provides revenue visibility. Valuation at 65× forward earnings limits position sizing — watch for pullbacks.

🌬️ Renewables: World's largest wind and solar operator with a regulated Florida utility for stability. Rapidly growing backlog of contracted renewables projects. Rate sensitivity risk already priced in at current levels.